Blood Collection Devices Market Share Report | Growth & Size 2030

Blood Collection Devices Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Blood Collection Tubes, Blood Collection Needles/Holders, Blood Collection Sets, and Others), Method (Manual Blood Collection and Automated Blood Collection), and End User (Hospitals and Pathology Laboratories, Blood Banks, and Others)

Publication Month : Oct 2023

  • Report Code : TIPHE100001279
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 176
Inquire Before Buy

PRICING

$4550

$3640

[Research Report] The market was valued at US$ 8,713.21 million in 2022 and is projected to reach US$ 14,021.79 million by 2030. It is estimated to register a CAGR of 6.1% from 2022 to 2030.

Market Insights and Analyst View:

A blood test is a painless and noninvasive procedure that also reduces the cost and time taken while diagnosing a medical problem. A blood test is a simple alternative to surgical biopsies that allows doctors to discover information about tumors from a simple blood sample. Due to the advancements in technology in terms of feasibility and processing times, the blood collection procedure has recently attracted considerable interest as a noninvasive alternative. Medical device manufacturers have made significant improvements in order to develop safer blood collection devices. The manufacturers and customers of blood collection devices have emphasized the reduction of bloodborne pathogen exposure and prevention of injury. Blood collection involves the use of various types of equipment and devices supplied by several manufacturers. Blood collection devices interact with blood to alter blood composition, serum, or plasma fractions and, in some cases, adversely affect laboratory tests. Vascular access devices might release coating substances and exert shear forces that lyse cells. Blood-dissolving tube additives can affect blood constituent stability and analytical systems. Hence, the surge in demand for minimally invasive or noninvasive diagnostic tests fuels the global blood collection devices market growth. The demand for blood collection devices is continuously growing due to the increase in the prevalence of cancer worldwide and the surge in demand for minimally invasive diagnostic tests.

Growth Drivers and Challenges:

Healthcare facilities across the globe are observing a substantial increase in the prevalence of cancer. According to the National Cancer Institute, cancer is increasingly becoming a global health issue. In 2020, there were 19.3 million new cancer cases, resulting in approximately 10 million cancer-related deaths worldwide. The World Health Organization estimated that, by 2040, there could be 28.9 million new cancer cases globally and ∼16.2 million cancer-related deaths yearly.

Moreover, in the UK, on average, 0.16 million people die due to cancer every year, per the data published in 2020 by Cancer Research UK. The most common method for a blood test for cancer is a liquid biopsy; this method is used for diagnosing non-small cell lung cancer (NSCLC) and screening other types of cancers such as breast, colorectal, prostate, gastrointestinal, and ovarian. As a result, blood collection tubes contribute to the organization's strategy for the early detection of cancer, allowing for quick treatment and enhancing cancer patients' survival rates. Thus, the increasing prevalence of cancer drives the global blood collection devices market.

There is a risk of percutaneous injury associated with a needle. According to a study published in Frontiers in Public Health, 2022, globally, each year, ~3 million needlestick injuries (NSIs) and other sharps-related injuries are sustained by hospital-based healthcare workers, which leads to severe risks and high expenses. Several diseases are transmitted through these injuries, including hepatitis B, acquired immune deficiency syndrome (AIDS), and hepatitis C.

As a result of accidental punctures, hazardous fluids can be injected into the body through the skin by contaminated needles. Injecting hazardous drugs is possible; however, the most significant concern is infection with infectious fluids, especially in the blood. Even small amounts of infectious fluid can spread diseases. According to a research article published in the Canadian Journal of Infectious Diseases and Medical Microbiology, the global pooled prevalence of needlestick injuries among healthcare workers in 2021 and 2020 was reported to be 56.2% and 32.4%, respectively. The study reported a high prevalence of occupational exposure to needlestick injuries among healthcare workers. Thus, the increased risk associated with needlestick injuries hamper the market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Blood Collection Devices Market: Strategic Insights

blood-collection-devices-market
Market Size Value inUS$ 8,713.21 million in 2022
Market Size Value byUS$ 14,021.79 million by 2030
Growth rateCAGR of 6.1% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The blood collection devices market is categorized on the basis of product, method, and end user. By product, the market is segmented into blood collection tubes, blood collection needles/holders, blood collection sets, and others. The blood collection devices market, by method, is bifurcated into manual blood collection and automatic blood collection. In terms of end user, the blood collection devices market is divided into hospitals and pathology laboratories, blood banks, and others. The blood collection devices market, based on geography, is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, Italy, UK, Spain, Benelux, Austria, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, Malaysia, Indonesia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, Rest of South & Central America).

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

Based on the product, the blood collection devices market is segmented into blood collection tubes, blood collection needles/holders, blood collection sets, and others. The blood collection tube segment is further bifurcated into evacuated blood collection tubes and micro-collection tubes. In 2022, the blood collection tubes segment held the largest share of the market. Also, the segment is expected to record the highest CAGR during the forecast period. Blood collection tubes are specimen-collecting containers used to collect the desired quantity of the blood sample. These tubes are pre-sterilized containers with closure caps. There are different varieties of blood collection tubes based on the content in the tubes, such as anticoagulants, stabilizers, enzymes, and other reagents. Micro-collection tubes are the blood collection devices used for the collection, storage, pretreatment, and transportation of capillary blood specimens. The product is primarily used for collecting blood samples of newborn babies, infants, prostrate patients in the ICU, and other patients. This type of product assists in collecting blood samples from patients who face difficulty in venous blood collection. The micro-collection tubes help to collect blood samples of less than 1 ml.

The blood collection devices market, by method, is bifurcated into manual blood collection and automatic blood collection. In 2022, the manual blood collection segment held a larger share of the market. However, the automated blood collection segment is anticipated to record a higher CAGR during the forecast period. The automated blood collection method allows the use of a fully automated system for blood collection. These systems are based on advanced technologies that help collect blood components such as platelets. This advanced blood collection method has minimal human interventions during the process. The system automatically monitors the donor's conditions. The automation systems also help efficiently manage the data generated during the process. For example, Trima Accel is an automated blood-collecting system provided by Terumo BCT Inc. The system has sensitive sensors that help monitor and detect errors or alerts about readings during blood collection. The system operates according to the donor's physical conditions and is continuously monitored during the procedure.

By end user, the blood collection devices market is categorized into hospitals and pathology laboratories, blood banks, and others. In 2022, the hospitals and pathology laboratories segment held the largest share of the market. In addition, the same segment is also expected to record the highest CAGR during the forecast period. Hospitals and pathology laboratories are equipped with specialized scientific equipment. The team of trained staff is assigned to manage, investigate, and rectify the problems associated with modern medical science in hospitals and pathology laboratories. The medical research teams are constantly working on introducing innovative technologies related to treatment methods, laboratory investigations, and other activities in the medical field. Patients generally prefer the hospital due to the availability of advanced options for the treatment of chronic conditions. Blood collection devices are frequently used in hospitals and pathology laboratories in order to diagnose and treat various diseases.

Blood Collection Devices Market, by Product – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis:

Based on geography, the blood collection devices market is categorized into five key regions—North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. The market in North America has been analyzed with a prime focus on three major countries—the US, Canada, and Mexico. North America held the largest share of the blood collection devices market in 2022. A rise in the demand for blood collection devices for the diagnostics of COVID-19, increasing incidence of chronic kidney diseases, government grants for research institutes to develop new blood-related equipment, and high R&D spending are a few of the prominent factors propelling the market growth.

The blood collection devices market in the US is expected to become the largest and fastest-growing market during the forecast period. The growth of the market is due to the rising advancements in blood purification procedures. The country has well-developed healthcare facility centers equipped with highly advanced equipment and instruments. The country is also experiencing increasing incidences of chronic diseases such as acute kidney injury (AKI) and multiple organ dysfunction syndromes or sepsis. Thus, the rising incidences of chronic diseases are expected to fuel the growth of the market in the coming years.

Blood Collection Devices Market Opportunity:

Rising Incidences of Chronic Diseases

According to the World Health Organization, the most noncommunicable disease-related deaths are cardiovascular diseases, accounting for ∼17 million people each year, followed by different forms of cancers, chronic respiratory diseases, and diabetes (including deaths associated with the kidney). Blood collection devices are used for drawing blood from the veins for cholesterol testing, as high cholesterol can cause heart stroke and heart attack. According to the World Heart Federation, high cholesterol causes 4.4 million deaths yearly, and ∼24% of cardiovascular-related deaths are attributable to high low-density lipoprotein (LDL) cholesterol. Per a study published in January 2023 by NCBI, in the US, the number of people aged 50 years and older will reach 221.13 million by 2050, a rapid increase from 137.25 million in 2020. People aged 50 and above are expected to suffer from at least one chronic disease, and the figure is projected to rise by 99.5% from 71.52 million in 2020 to 142.66 million by 2050. Also, it is projected that ~14 million people are likely to suffer from multimorbidity by 2050. The treatment of chronic diseases requires blood tests and long-term medications; hence, the growing incidence of chronic diseases is anticipated to create numerous growth opportunities for the market players in the coming years.  

Competitive Landscape and Key Companies:

A few of the prominent players operating in the global blood collection devices market are Becton Dickinson and Co, Terumo Corp, Cardinal Health Inc, SARSTEDT AG & Co KG, Nipro Corp, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, Greiner Bio-One International GmbH, FL Medical SRL, and IntervacTechnology OU. These companies focus on the development of new technologies, advancements in existing products, and expansion of geographic footprint to meet the growing consumer demand worldwide and expand their product range in specialty portfolios. Companies operating in the global blood collection devices market are implementing various inorganic and organic strategies. A few of them are mentioned below:

  • In September 2023, FL Medical SRL launched a new blood collection set under its brand Vacumed. The Vacumed Tech Blood collection set is designed to provide safety, improve efficiency, and ensure easy use during the process.
  • In August 2023, FL Medical SRL launched Promed racks for test tubes, a laboratory management equipment for samples. The newly launched test tube racks are autoclavable and allow to fit all sizes of test tubes available in the market.
  • In October 2022, BD and Magnolia Medical Technologies Inc announced a commercial agreement with an aim to help hospitals in the US reduce blood culture contamination in order to improve testing accuracy, along with clinical outcomes.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Method, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which end user segment is dominating the blood collection devices market?

The blood collection devices market, based on sample type, classified into blood banks, hospitals and pathology laboratories, and others. In 2022, the hospitals and pathology laboratories segment held the largest share of the market. In addition, the same segment is also expected to record the highest CAGR during 2022-2030.

Which method segment is dominating the blood collection devices market?

The blood collection devices market, based on method, is bifurcated into automated and manual blood collection. In 2022, the manual blood collection segment held a larger share of the market. However, the automated blood collection segment is anticipated to record a higher CAGR during 2022-2030.

Which region is the fastest growing the blood collection devices market?

Asia Pacific is expected to be the fastest growing region in the blood collection devices market. The projected growth of the market in the coming years is attributed to the high prevalence of cancer, diabetes, and cardiovascular disease; government initiatives to boost the medical device industry; and increasing capacity of medical device manufacturing facilities in Asia Pacific countries.

Which product segment is dominating the blood collection devices market?

The blood collection devices market, based on product, is segmented into blood collection tubes, blood collection needles/holders, blood collection sets, and others. The blood collection tube segment is further bifurcated into evacuated blood collection tubes and micro-collection tubes. In 2022, the blood collection tubes segment held the largest share of the market. Moreover, the same segment is expected to record the highest CAGR during 2022-2030.

What is blood collection device?

Blood collection devices help in safe withdrawal of blood. Blood is collected from donor to perform various diagnostic tests. Needles & Syringes, and lancets and other devices are used for arterial and venous blood collection. Arterial blood collection has various advantages such as arterial blood gas sampling, and intraoperative blood salvage.

Which country is dominated the blood collection devices market?

US holds the largest market share in blood collection devices market. The US has a well-developed healthcare sector equipped with highly advanced equipment and instruments. The country is experiencing increasing incidences of chronic diseases [such as acute kidney injury (AKI)] and multiple organ dysfunction syndromes or sepsis, which is likely to favor the growth of the blood collection devices market.

What are the driving factors for the blood collection devices market across the globe?

The factors that are driving growth of the market are increase in prevalence of cancer worldwide and surge in demand for minimally invasive diagnostic tests.

Who are the major players in the blood collection devices market?

The blood collection devices market majorly consists of the players such as Becton Dickinson and Co, Terumo Corp, Cardinal Health Inc, SARSTEDT AG & Co KG, Nipro Corp, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, Greiner Bio-One International GmbH, FL Medical SRL, and IntervacTechnology OU among others.

The List of Companies - Blood Collection Devices Market

  1. Becton Dickinson and Co
  2. Terumo Corp  
  3. Cardinal Health Inc  
  4. SARSTEDT AG & Co KG
  5. Nipro Corp  
  6. Thermo Fisher Scientific Inc
  7. Sekisui Chemical Co Ltd
  8. Greiner Bio-One International GmbH  
  9. FL Medical SRL
  10. IntervacTechnology OU

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Blood Collection Devices Market